Showing results (2871-2880 of 6,794) with videos related to
Sort By:
Pageof 680
Clinical Therapeutics|June 23, 2009
Results of a model analysis to estimate cost utility and value of information for intravenous immunoglobulin in Canadian adults with chronic immune thrombocytopenic purpuraFeng Xie, Gord Blackhouse, Nazila Assasi, et al.Clinical Therapeutics|January 27, 2009
Relative bioavailability of tizanidine hydrochloride capsule formulation compared with capsule contents administered in applesauce: a single-dose, open-label, randomized, two-way, crossover study in fasted healthy adult subjectsHerbert R Henney, Anthony Fitzpatrick, Johnston Stewart, et al.Clinical Therapeutics|January 27, 2009
A US multicenter, retrospective, observational study of erythropoiesis-stimulating agent utilization in anemic, critically ill patients admitted to the intensive care unitGretchen M Brophy, Valerie Sheehan, Marc J Shapiro, et al.Clinical Therapeutics|January 27, 2009
Antihypertensive efficacy and tolerability of irbesartan/hydrochlorothiazide in hypertensive patients stratified by body mass index and type 2 diabetes mellitus status: a post hoc subgroup analysis of the Irbesartan/HCTZ Blood Pressure Reductions in Diverse Patient Populations trialAndrew J Lewin, Matthew R WeirClinical Therapeutics|January 27, 2009
Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: post hoc analysis of a 12 week, prospective, randomized, active-controlled, open-label, parallel-group trial in adultsAlan Kivitz, Michael Fairfax, Eric A Sheldon, et al.Clinical Therapeutics|January 27, 2009
Adherence to guidelines for use of erythropoiesis-stimulating agents in patients with chemotherapy-induced anemia: results of a retrospective study of an electronic medical-records database in the United States, 2002-2006Weixiu Luo, Beth L Nordstrom, Kathy Fraeman, et al.Clinical Therapeutics|December 26, 2008
Infliximab and methotrexate in the treatment of rheumatoid arthritis: a systematic review and meta-analysis of dosage regimensElias Zintzaras, Issa J Dahabreh, Stavroula Giannouli, et al.Clinical Therapeutics|December 26, 2008
A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetesPriscilla Hollander, John Cooper, Jesper Bregnhøj, et al.Clinical Therapeutics|December 26, 2008
Conjunctival tissue pharmacokinetic properties of topical azithromycin 1% and moxifloxacin 0.5% ophthalmic solutions: a single-dose, randomized, open-label, active-controlled trial in healthy adult volunteersGail Torkildsen, Terrence P O'BrienClinical Therapeutics|December 26, 2008
Comparison of propofol, droperidol, and metoclopramide for prophylaxis of postoperative nausea and vomiting after breast cancer surgery: a prospective, randomized, double-blind, placebo-controlled study in Japanese patientsYoshitaka Fujii, Michiyo ItakuraPageof 680